Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

This study has suspended participant recruitment.
(submitter requested that status change via CRM 27718)
Sponsor:
Information provided by (Responsible Party):
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT01016730
First received: November 18, 2009
Last updated: September 25, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: September 2014
  Estimated Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)